The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KEYSTEP-008: Pembrolizumab (pembro)-based combinations for microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC).
 
Thierry Andre
Honoraria - Bristol-Myers Squibb; Merck; Merck Serono; Sanofi; Seagen; SERVIER
Consulting or Advisory Role - Abbvie; Aptitude Health; Aptitude Health; Bristol-Myers Squibb; Exelixis; Gilead Sciences; GlaxoSmithKline; Medicenna; MSD Oncology; Nimbus Therapeutics; Nordic Bioscience; Pfizer; Sanofi; Sanofi; Seagen; SERVIER; Takeda
Speakers' Bureau - Biocartis
Travel, Accommodations, Expenses - Bristol-Myers Squib; Bristol-Myers Squibb; Merck; MSD Oncology; Takeda
Other Relationship - Inspirna
(OPTIONAL) Uncompensated Relationships - Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group; ARCAD Foundation; ARCAD Foundation
 
Filippo Pietrantonio
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daiichi-Sankyo; Incyte; Ipsen; Johnson&Johnson; Merck Serono; MSD Oncology; Pierre Fabre; Rottapharm Biotech; Seagen; SERVIER; Takeda
Consulting or Advisory Role - Agenus; Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; BMS; Daiichi-Sankyo; Gilead Sciences; GlaxoSmithKline; Incyte; Jazz Pharmaceuticals,; Johnson & Johnson/Janssen; Merck Serono; MSD Oncology; Pfizer; Pierre Fabre; Revolution Medicines; Rottapharm Biotech; SERVIER; Takeda
Research Funding - Agenus (Inst); Amgen (Inst); Astrazeneca (Inst); BeOne (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Johnson & Johnson/Janssen (Inst); Lilly (Inst); Rottapharm Biotech (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Johnson & Johnson/Janssen; Merck Serono; Pierre Fabre; Takeda Science Foundation
 
Suayib Yalcin
Stock and Other Ownership Interests - Humana; Pfizer
Honoraria - Gen
Consulting or Advisory Role - Amgen; Bayer; bms; Gen; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche
Speakers' Bureau - Bayer; Bayer; gen ilaç; Merck Serono; Novartis; Novartis; Pfizer; Roche
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - Gen; Roche
 
Joong Bae Ahn
Research Funding - Merck; Sanofi
 
Sonali Dasgupta
Travel, Accommodations, Expenses - SERVIER; Takeda
 
Myriam Chalabi
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene (Inst); MSD (Inst); Roche/Genentech
Research Funding - Agenus (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Tae-You Kim
No Relationships to Disclose
 
Kai-Keen Shiu
Honoraria - Bayer; Bristol-Myers Squibb; Merck Serono; MSD Oncology; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; GlaxoSmithKline; Mirati Therapeutics; MSD Oncology; Nouscom; Roche; Seagen; Takeda
Research Funding - AstraZeneca (Inst); BioNTech SE (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst); Nouscom (Inst); Roche (Inst)
 
Luis Corrales
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pfizer; Roche
Travel, Accommodations, Expenses - Addium; AstraZeneca; Merck; MSD; Pfizer
 
Sara Lonardi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Beigene; Bristol-Myers Squibb; Daiichi Sankyo; Fosun Pharma; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD; Nimbus Therapeutics; Rottapharm Biotech; SERVIER; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD Oncology; Pierre Fabre; Roche; Servier
Research Funding - Amgen; AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck Serono; Roche (Inst)
 
Mariusz Kwiatkowski
No Relationships to Disclose
 
Paula Jimenez-Fonseca
No Relationships to Disclose
 
Mehmet Sendur
Honoraria - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - Abdi Ibrahim; Abdi Ibrahim; Amgen; Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche; Takeda
 
Goda Jonuskiene
Travel, Accommodations, Expenses - AstraZeneca; SERVIER
 
Javier Sastre Valera
Consulting or Advisory Role - Amgen; Astellas Pharma; BMS; Merck Serono; MSD Oncology; Roche; SERVIER; Takeda
Speakers' Bureau - Ipsen; Lilly; Merck Serono; MSD; Pfizer; Roche; SERVIER; Shire
Travel, Accommodations, Expenses - Ipsen; Merck Serono
 
Mahmut Gumus
Honoraria - Bayer (Inst); Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst)
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); Gen (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Roche; Takeda (Inst)
Speakers' Bureau - Amgen (Inst); MSD Oncology (Inst); Novartis (Inst); Polipharma (Inst); Roche (Inst)
Research Funding - Amgen (Inst); MSD Oncology (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Amos Odeleye-Ajakaye
Employment - Merck
Stock and Other Ownership Interests - Merck
 
David Fogelman
Employment - Merck
Stock and Other Ownership Interests - GTx; Merck
 
David Adelberg
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Tae Won Kim
Employment - Asan Medical Center
Research Funding - Genome Insight (Inst); Roche/Genentech (Inst)